Hilda Hernandez-Barry

Hilda Hernandez-Barry

Auto-generated profile, based on publicly available information

Hilda Hernandez-Barry

Department of Biochemical and Cellular Pharmacology, Genentech, Inc., South San Francisco, California, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2021 in mBio
Verified
Journal Article
Open access
KKKimberly K. Kajihara
Kimberly K. Kajihara
HPHomer Pantua
Homer Pantua
HHHilda Hernandez-Barry
Hilda Hernandez-Barry
MHMeredith Hazen
Meredith Hazen
KDKiran Deshmukh
Kiran Deshmukh
WHWouter L. W. Hazenbos
Wouter L. W. Hazenbos
Antibiotic treatment of life-threatening P. aeruginosa infections is associated with low clinical success, despite the availability of antibiotics that are active in standard microbiological in vitro assays, affirming the need for new therapeutic approaches. Antibiotics often fail in the preclinical stage due to insufficient efficacy against P. aeruginosa .